Literature DB >> 7491115

Steroidogenic factor 1 is the essential transcript of the mouse Ftz-F1 gene.

X Luo1, Y Ikeda, D A Schlosser, K L Parker.   

Abstract

Targeted disruption of the mouse Ftz-F1 gene, which encodes the orphan nuclear receptors steroidogenic factor 1 (SF-1) and embryonal long terminal repeat-binding protein (ELP), established that this gene is essential for development of the primary steroidogenic tissues and for male sexual differentiation. Associated with these dramatic developmental abnormalities, all Ftz-F1-disrupted mice died in the immediate postnatal period and had very low glucocorticoid levels. In this report, we show that treatment with corticosteroids markedly prolonged survival of the Ftz-F1-disrupted mice, proving that steroid hormone deficiency causes their death. We also generated SF-1-specific knockout mice with a targeting construct that specifically disrupted the SF-1 coding sequence without impairing the ELP protein. The phenotype of the SF-1-specific knockout mice was indistinguishable from that observed in Ftz-F1-disrupted mice that lack both SF-1 and ELP. Taken together, these results indicate that SF-1 is the Ftz-F1-encoded protein that is required for multiple aspects of endocrine development and for postnatal survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491115     DOI: 10.1210/mend.9.9.7491115

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

1.  Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia.

Authors:  K M Caron; S C Soo; W C Wetsel; D M Stocco; B J Clark; K L Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal E box element.

Authors:  L L Heckert
Journal:  Mol Endocrinol       Date:  2001-05

3.  Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors.

Authors:  Sergei G Tevosian; Elizabeth Jiménez; Heather M Hatch; Tianyu Jiang; Deborah A Morse; Shawna C Fox; Maria B Padua
Journal:  Endocrinology       Date:  2015-05-01       Impact factor: 4.736

Review 4.  Ventromedial hypothalamus glucose-inhibited neurones: A role in glucose and energy homeostasis?

Authors:  Pamela R Hirschberg; Pallabi Sarkar; Suraj B Teegala; Vanessa H Routh
Journal:  J Neuroendocrinol       Date:  2019-08-04       Impact factor: 3.627

5.  Expression of steroidogenic factor 1 in the testis requires an E box and CCAAT box in its promoter proximal region.

Authors:  M A Daggett; D A Rice; L L Heckert
Journal:  Biol Reprod       Date:  2000-03       Impact factor: 4.285

6.  Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.

Authors:  R L Habiby; P Boepple; L Nachtigall; P M Sluss; W F Crowley; J L Jameson
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription.

Authors:  J J Tremblay; J Drouin
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.

Authors:  Lorin M Henrich; Jeffrey A Smith; Danielle Kitt; Timothy M Errington; Binh Nguyen; Abdulmaged M Traish; Deborah A Lannigan
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 9.  Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolism.

Authors:  Jinhan He; Qiuqiong Cheng; Wen Xie
Journal:  Mol Endocrinol       Date:  2009-09-17

10.  Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening.

Authors:  Franck Madoux; Xiaolin Li; Peter Chase; Gina Zastrow; Michael D Cameron; Juliana J Conkright; Patrick R Griffin; Scott Thacher; Peter Hodder
Journal:  Mol Pharmacol       Date:  2008-03-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.